260 related articles for article (PubMed ID: 32923264)
21. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
Zanichelli A; Mansi M; Periti G; Cicardi M
Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
[TBL] [Abstract][Full Text] [Related]
24. [Guidelines for the diagnosis and treatment of hereditary angioedema].
Marković AS; Rozmanić V; Anić B; Aberle N; Racić G; Novak S; Sunara D; Grdinić B; Karadza-Lapić L; Radas MR; Karanović B; Kvenić B
Lijec Vjesn; 2014; 136(5-6):117-29. PubMed ID: 25154179
[TBL] [Abstract][Full Text] [Related]
25. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
26. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.
Piras V; Alves F; Gonçalo M
Dermatol Ther; 2019 Nov; 32(6):e13098. PubMed ID: 31579975
[TBL] [Abstract][Full Text] [Related]
27. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
28. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
Henry Li H; Riedl M; Kashkin J
Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
[TBL] [Abstract][Full Text] [Related]
29. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
Bork K
Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
[TBL] [Abstract][Full Text] [Related]
30. A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1.
Farkas H; Máj C; Kenessey I; Sebestyén A; Krencz I; Pápay J; Cervenak L
Allergy Asthma Clin Immunol; 2022 Jul; 18(1):60. PubMed ID: 35787812
[TBL] [Abstract][Full Text] [Related]
31. Novel Therapies for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review of Current Evidence.
Riha HM; Summers BB; Rivera JV; Van Berkel MA
J Emerg Med; 2017 Nov; 53(5):662-679. PubMed ID: 28939396
[TBL] [Abstract][Full Text] [Related]
32. Fresh frozen plasma for the treatment of hereditary angioedema.
Prematta M; Gibbs JG; Pratt EL; Stoughton TR; Craig TJ
Ann Allergy Asthma Immunol; 2007 Apr; 98(4):383-8. PubMed ID: 17458436
[TBL] [Abstract][Full Text] [Related]
33. An evidence based therapeutic approach to hereditary and acquired angioedema.
Bork K
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
[TBL] [Abstract][Full Text] [Related]
34. Hereditary angioedema attack: what happens to vasoactive mediators?
Ferrara AL; Bova M; Petraroli A; Veszeli N; Galdiero MR; Braile M; Marone G; Cristinziano L; Marcella S; Modestino L; Farkas H; Loffredo S
Int Immunopharmacol; 2020 Jan; 78():106079. PubMed ID: 31841756
[TBL] [Abstract][Full Text] [Related]
35. Hereditary angioedema: epidemiology, management, and role of icatibant.
Ghazi A; Grant JA
Biologics; 2013; 7():103-13. PubMed ID: 23662043
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
37. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.
Bork K; Hardt J; Witzke G
J Allergy Clin Immunol; 2012 Sep; 130(3):692-7. PubMed ID: 22841766
[TBL] [Abstract][Full Text] [Related]
38. Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor.
McKibbin L; Barber C; Kalicinsky C; Warrington R
Allergy Asthma Clin Immunol; 2019; 15():66. PubMed ID: 31749860
[TBL] [Abstract][Full Text] [Related]
39. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
[TBL] [Abstract][Full Text] [Related]
40. Chapter 22: Hereditary and acquired angioedema.
Georgy MS; Pongracic JA
Allergy Asthma Proc; 2012; 33 Suppl 1():73-76. PubMed ID: 22794695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]